The Use of Biokinetics and in Vitro Methods in Toxicological Risk Evaluation

Anon. (1994). ECVAM News & Views. ATLA 22, 7–11.

Blaauboer B.J. (1995). The use of hepatocyte cultures in pharmacology and toxicology. In Proceedings of an EU Meeting on Hepatocyte-based In Vitro Models and their Application in Pharmacotoxicology, pp. 1–9. Brussels: VUB Press.

Walum E. , Balls M. , Bianchi V. , Blaauboer B. , Bolcsfoldi G. , Guillouzo A. , Moore G.A. , Odland L. , Reinhardt C. , and Spielmann H. (1992). ECITTS: an integrated approach to the application of in vitro test systems to the hazard assessment of chemicals. ATLA 20, 406–428.

Blaauboer B.J. , Balls M. , Bianchi V. , Bolcsfoldi G. , Guillouzo A. , Moore G.A. , Odland L. , Reinhardt C.A. , Spielmann H. , and Walum E. (1994). The ECITTS integrated toxicity testing scheme: the application of in vitro test systems to the hazard assessment of chemicals. Toxicology in Vitro 8, 845–846.

Barratt M.D. , Castell J.V. , Chamberlain M. , Combes R.D. , Dearden J.C. , Fentem J.H. , Gerner I. , Guiliani A. , Gray T.J.B. , Livingstone D.J. , Provan W.M. , Rutten F.A.J.J.L. , Verhaar H.J.M. , and Zbinden P. (1995). The integrated use of alternative approaches for predicting toxic hazard. The report and recommendations of ECVAM workshop 8. ATLA 23, 410–429.

Andersen M.E. , and Krishnan K. (1994). Physiologically based pharmacokinetic modelling in toxicology. In Principles and Methods of Toxicology, 3rd edn (ed. Hayes A. W. ), pp. 149–188. New York: Raven Press.

Sato A. , and Nakajima T. (1979). A structure-activity relationship of some chlorinated hydrocarbons. Archives of Environmental Health 79, 69–75.

Fiserova-Bergerova V. , and Diaz M.L. (1986). Determination and prediction of tissue-gas partition coefficients. International Archives of Occupational and Environmental Health 58, 75–87.

Gargas M.L. , Burgess R.J. , Voisard D.E. , Cason G.H. , and Andersen M.E. (1989). Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicology and Applied Pharmacology 98, 87–99.

Pacifici G.M. , and Viani A. (1992). Methods of determining plasma and tissue binding of drugs. Clinical Pharmacokinetics 23, 449–468.

Jepson G.W. , Hoover D.K. , Black R.K. , McCafferty J.D. , Mahle D.A. , and Gearhart J.M. (1994). A partition coefficient determination method for non-volatile chemicals in biological tissues. Fundamental and Applied Toxicology 22, 519–524.

Patterson S. , and Mackay D. (1989). Correlation of tissue, blood and air partition coefficients of volatile organic chemicals. British Journal of Industrial Medicine 46, 321–328.

Poulin P. , and Krishnan K. (1995). A biologically-based algorithm for predicting human tissue-blood partition coefficients of organic chemicals. Human and Experimental Toxicology 14, 273–280.

Gargas M.L. , Seyboldt P.G. , and Andersen M.E. (1988). Modelling the tissue solubilities and metabolic rate constants (V_max) of halogenated methanes, ethanes and ethylenes. Toxicology Letters 43, 235–256.

Connell D.W. , Braddock R.D. , and Mani S.V. (1993). Prediction of the partition coefficient of lipophilic compounds in the air-mammal tissue system. Science of the Total Environment Suppl. 2, 1383–1396.

Chou J.T. , and Jurs P.C. (1980). Computation of partition coefficients from molecular structures by a fragment addition method. In Physical and Chemical Properties of Drugs (ed. Yalkowsky S.H. , Sinkula A.A. , Valvani S.C. ), pp. 163–199. New York: Marcel Dekker.

Kier L.B. (1980). Molecular connectivity as a descriptor of structure for SAR analysis In Physical and Chemical Properties of Drugs (ed. Yalkowsky S.H. , Sinkula A.A. , Valvani S.C. ), pp. 277–319. New York: Marcel Dekker.

Jackson J. (1987). Drug transport across gastrointestinal epithelia. In Physiology of the Gastrointestinal Tract, 2nd edn. (ed. Johnson L.R. ), pp. 1597–1621. New York: Raven Press.

Spiller R.C. (1994). Intestinal absorptive function. Gut 35, Suppl. 1, S5–S9.

Scheman M. , and Ehrlein H.J. (1986). Postprandial patterns of canine jejunal motility and transit of luminal content. Gastroenterology 90, 991–1000.

Houston J.B. , Upshall D.J. , and Bridges J.W. (1974). A re-evaluation of the importance of partition coefficients in the gastrointestinal absorption of nutrients. Journal of Pharmacology and Experimental Therapeutics 189, 244–254.

Clewell H.J. 3rd , & Jarnot B.J. (1994). Incorporation of pharmacokinetics in non-cancer risk assessment: example with chloropentafluorobenzene. Risk Analysis 14, 265–276.

Ramsey C.J. , and Andersen M.E. (1994). A physiologically-based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicology and Applied Pharmacology 73, 159–175.

Staats D.A. , Fisher J.W. , and Connolly R.B. (1991). Gastrointestinal absorption of xenobiotics in physiologically-based pharmacokinetic models: a two-compartment description. Drug Metabolism and Disposition 19, 144–148.

Semino G. , Lilly P.D. , and Andersen M.E. (1995). A multi-compartment sequential transport model of the gastrointestinal absorption. The Toxicologist 15, 273 (abstract).

Frederick C.B. , Potter D.W. , Chang-Mateau M.I. , and Andersen M.E. (1992). A physiologically based pharmacokinetic and pharmacodynamic model to describe the oral dosing of rats with ethylacrylate and its implication for risk assessment. Toxicology and Applied Pharmacology 114, 246–260.

Bischoff K.B. , Dedrick R.L. , Zaharko D.S. , and Longsreth J.A. (1971). Methotrexate pharmacokinetics. Journal of Pharmaceutical Sciences 60, 1128–1133.

Farris F.F. , Dedrick R.L. , Allen P.V. , and Smith J.C. (1993). Physiological model for pharmacokinetics of methylmercury in the growing rat. Toxicology and Applied Pharmacology 119, 74–90.

Leibnovitz A. , Stinson J.C. , McCombs C.E. , Masur K.C. , and Mabry N.D. (1976). Classification of human colorectal adenocarcinoma cell lines. Cancer Research 36, 4562–4569.

Hidalgo I.J. , Raub T.J. , & Borchardt R.T. (1989). Characterisation of the human colon carcinoma cell line (CaCo-2) as a model system for intestinal epithelial permeability. Gastroenterology 96, 736–749.

Wils P. , Warnery A. , Phung-Ba V. , and Scherman D. (1994). Differentiated intestinal epithelial cell lines as in vitro models for predicting the intestinal absorption of drugs. Cell Biology and Toxicology 10, 393–397.

Artusson P. , and Karlsson J. (1991). Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochemical and Biophysical Research Communications 175, 880–885.

Fiserova-Bergerova V. ed. (1983). Modelling of Inhalation Exposure to Vapors: Uptake, Distribution and Elimination., 166 pp. Boca Raton, FL, USA: CRC Press.

Gargas M. , Medlinsky M.A. , and Andersen M.E. (1993). Advances in physiological modelling approaches for understanding the disposition of inhaled vapors. In Toxicology of the Lung (ed. Gardner D.E. , Crapo J.D. , McClellan R.O. ), pp. 461–483. New York: Raven Press.

Johanson G. (1991). Modelling of respiratory exchange of polar solvents. Annals of Occupational Hygiene 35, 323–339.

Medinsky M.A. , Kimbress J.S. , Morris J.B. , Gerde P. , and Overton J.H. (1993). Advances in biologically based models for respiratory tract uptake of inhaled volatiles. Fundamental and Applied Toxicology 20, 265–272.

Gerde P. , and Dahl A.R. (1991). A model for the uptake of inhaled vapors in the nose of the dog during cyclic breathing. Toxicology and Applied Pharmacology 109, 276–288.

Tsu M.E. , Babb A.L. , Sugiyama E.M. , and Hlastala M.O. (1991). Dynamics of soluble gas exchange in the airways. II. Effects of breathing conditions. Respiratory Physiology 83, 261–276.

Morris J.B. (1990). First-pass metabolism of inspired ethyl acetate in the upper respiratory tracts of the F344 rat and Syrian hamster. Toxicology and Applied Pharmacology 102, 331–345.

Morris J.B. , Clay RJ. , and Cavanagh D.G. (1986). Species differences in upper respiratory tract deposition of acetone and ethanol vapors. Fundamental and Applied Toxicology 7, 671–680.

Johanson G. , and Filser J.G. (1992). Experimental data from closed chamber gas uptake studies in rodents suggest lower uptake rate of chemical than calculated from literature values on alveolar ventilation. Archives of Toxicology 66, 291–295.

Anon. (1966). Disposition and retention models for internal dosimetry of the human respiratory tract (Task Group on Lung Dynamics). Health Physics 12, 173–207.

Snipes M.B. (1995). Pulmonary retention of particles and fibers: biokinetics and effects of exposure concentrations. In Concepts in Inhalation Toxicology (ed. McClellan R.O. , Henderson R.F. ), pp. 225–255. Washington, DC: Taylor & Francis.

Overton J.H. (1984). Physicochemical processes and the formulation of dosimetry models. Journal of Toxicology and Environmental Health 13, 273–294.

Gerde P. , Muggenburg B.A. , and Henderson R.F. (1993). Disposition of polycyclic aromatic hydrocarbons in the respiratory tract of the Beagle dog. III. Mechanisms of dosimetry. Toxicology and Applied Pharmacology 121, 328–334.

Gerde P. , Medinsky M.A. , and Bond J.A. (1991). Particle-associated polycyclic aromatic hydrocarbons: a reappraisal of their possible role in pulmonary carcinogenesis. Toxicology and Applied Pharmacology 108, 1–13.

Howes D. , Guy R. , Hadgraft J. , Heylings J. , Hoeck U. , Kemper F. , Maibach H. , Marty J.P. , Merk H. , Parra J. , Rekkas D. , Rondelli I. , Schaefer H. , Täuber U. , and Verbiese N. (1996). Methods for assessing percutaneous absorption. The report and recommendations of ECVAM workshop 13. ATLA 24, 81–106.

Forslind B. (1994). A domain mosaic model of the skin barrier. Acta Dermato-Venereologica (Stockholm) 74, 1–6.

Friend D.R. (1992). In vitro permeation techniques. Journal of Controlled Release 18, 235–248.

van de Sandt J.J.M. , Rutten A.A.J.J.L. , & van Ommen B. (1993). Species specific cutaneous biotransformation of the pesticide propoxur during percutaneous absorption in vitro. Toxicology and Applied Pharmacology 123, 144–150.

Riviere J.E. , Bowman K.F. , Monteiro-Riviere N.A. , Dix L.P. , and Carver M.P. (1986). The isolated perfused porcine skin flap (IPPSF). I. A novel in vitro model for percutaneous absorption and cutaneous toxicology studies. Fundamental and Applied Toxicology 7, 444–453.

Mattie D.R. , Bates G.D. Jr. , Jepson G.W. , Fisher J.W. , and McDougal J.N. (1994). Determination of skin-air partition coefficients for volatile chemicals: experimental method and applications. Fundamental and Applied Toxicology 22, 51–57.

Barratt M.D. (1995). Quantitative structure-activity relationships for skin permeability. Toxicology in Vitro 9, 27–37.

Potts R.O. , McNeill S.C. , Desbonnet C.R. , and Wakshull E. (1989). Transdermal drug transport and metabolism. II. The role of competing kinetic events. Pharmaceutical Research 6, 119–124.

Riviere J.E. , and Williams P.L. (1992). Pharmacokinetic implications of changing blood flow in skin. Journal of Pharmaceutical Sciences 81, 601–602.

Auton T.R. , Westhead D.R. , Woollen B.H. , Scott R.C. , and Wilks M.F. (1994). A physiologically based mathematical model of dermal absorption in man. Human and Experimental Toxicology 13, 51–60.

Joo F. (1993). The blood-brain barrier in vitro: the second decade. Neurochemistry International 23, 499–521.

Pardridge W. ed. (1993). The Blood-Brain Barrier. Cellular and Molecular Biology., 357 pp. New York: Raven Press.

Heller N. , Gloor S. , and Reinhardt C.A. The blood-brain barrier in vitro: characterisation and potential use for pharmacotoxicological screening. In Vitro Toxicology, in press.

Selig A. , Gottschlich R. , and Devant R.M. (1994). A method to determine the ability of drugs to diffuse through the blood-brain barrier. Proceedings of the National Academy of Sciences of the USA 91, 68–72.

van Bree J.B.M.M. , De Boer A.G. , Danhof M. , Ginsel L.A. , and Breimer D.D. (1988). Characterisation of an “in vitro” blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs. Journal of Pharmacology and Experimental Therapeutics 247, 1233–1239.

Joly B. , Fardel O. , Cecchelii R. , Chesné C. , Puozzo C. , and Guillouzo A. (1995). Selective drug transport and P-glycoprotein activity in an in vitro blood-brain barrier model. Toxicology in Vitro 9, 357–364.

Dehouck M.P. , Méresse S. , Delorme J. , Fruchart J.C. , and Cecchelli R. (1990). An easier reproducible and mass-production method to study the blood-brain barrier “in vitro”. Journal of Neurochemistry 54, 1798–1801.

Veronesi B. Characterization of the Madin-Darby canine kidney (MDCK). cell as an in vitro model of the blood-brain barrier. Neurotoxicology, in press.

Wilkinson G.R. (1987). Clearance approaches in pharmacology. Pharmacological Reviews 39, 1–47.

Boxenbaum H. (1980). Interspecies variation in liver weight, hepatic blood flow and antipyrine intrinsic clearance: extrapolation of data to benzodiazepines and phenytoin. Journal of Biokinetics and Biopharmaceutics 8, 165–176.

Houston J.B. (1994). Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochemical Pharmacology 47, 1469–1479.

Worboys P.D. , Bradbury A. , and Houston J.B. (1995). Kinetics of drug metabolism in rat liver slices. Drug Metabolism and Disposition 23, 393–397.

Kedderis G.L. , Carfagna M.A. , Held S.D. , Bartra R. , Murphy J.E. , and Gargas M.L. (1993). Kinetic analysis of furan biotransformation by F-334 rats in vivo and in vitro. Toxicology and Applied Pharmacology 123, 274–282.

Kedderis G.L. , Held S.D. , and Gargas M.L. (1993). Prediction of chemical pharmacokinetics in vivo using freshly isolated hepatocytes in vitro. ISSX Proceedings 4, 61.

Kedderis G.L. , Held S.D. , and Bartra R. (1995). Kinetics of acrylonitrile biotransformation by isolated rat hepatocytes. The Toxicologist 15, 283–284.

Bayliss M.K. , Bell J.A. , Jenner W.N. , and Wilson K. (1990). The prediction of the intrinsic clearance of loxtidine from kinetic studies in rat, dog and human hepatocytes. Biochemical Society Transactions 18, 1198–1199.

Gargas M.L. , Andersen M.E. , & Clewell H.J. 3rd (1986). A physiologically based simulation approach for determining metabolic constants from gas uptake data. Toxicology and Applied Pharmacology 86, 341–352.

Gargas M.L. , Kedderis G.L. , Fennell T.R. , and Andersen M.E. (1990). A physiologically based biokinetic (PBPK) model for acrylonitrile (ACN) in the rat. The Toxicologist 10, 216.

Evelo C.T.A. , Oostendorp J.G.M. , Ten Berge W.F. , & Borm P.J.A. (1993). Physiologically based toxicokinetic modelling of 1,3-butadine: lung metabolism becomes more important at low doses. Environmental Health Perspectives 101, 496–502.

Rauws A.G. , and Groen K. (1994). Future perspectives on toxicokinetics: a regulator's view. Drug Information Journal 28, 295–300.

Gulden M. , Seibert H. , & Voss J-U. (1994). Inclusion of physicochemical data in quantitative comparisons of in vitro and in vivo toxic potencies ATLA 22, 185–192.

Bondesson I. , Ekwall B. , Hellberg S. , Romert L. , Stenberg K. , and Walum E. (1989). MEIC: a new international multicenter project to evaluate the relevance to human toxicity of in vitro cytotoxicity tests. Cell Biology and Toxicology 5, 331–347.

Gulden M. , Seibert H. , & Voss J-U. (1994). The use of cultured skeletal muscle cells in testing for acute systemic toxicity. Toxicology in Vitro 8, 779–782.

Seibert H. , Gulden M. , & Voss J-U. (1994). An in vitro testing strategy for the classification and labelling of chemicals according to their potential acute lethal potency. Toxicology in Vitro 8, 847–850.

Reitz R.H. , Mendrala A.L. , Corley T.A. , Quast J.F. , Gargas M.L. , Andersen M.E. , Staats D.A. , and Conolly R.B. (1990). Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modelling. Toxicology and Applied Pharmacology 105, 443–459.

Beck B.D. , Conolly R.B. , Dourson M.L. , Guth D. , Hattis D. , Kimmel C. , and Lewis S.C. (1993). Improvements in quantitative non-cancer risk assessment. Fundamental and Applied Toxicology 20, 1–14.